pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
lanadelumab
Takhzyro (lanadelumab-flyo)
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Takeda Pharmaceuticals USA Inc
0 catalysts
Marketed
landiolol hydrochloride
Rapiblyk (landiolol hydrochloride)
Atrial Fibrillation
AOP Health
0 catalysts
Marketed
lanreotide acetate PR
Somatuline Depot (lanreotide acetate)
Acromegaly
Ipsen Biopharmaceuticals Inc
0 catalysts
← prev
page 189 of 231
next →
131
Pain89
Neurology1
Marketed
lanthanum carbonate
Lanthanum Carbonate (lanthanum carbonate)
Hyperphosphatemia In Chronic Kidney Disease
Barr Laboratories Inc
0 catalysts
Marketed
lapatinib ditosylate
Lapatinib (lapatinib ditosylate)
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
Lupin Ltd
0 catalysts
Phase 2
laromestrocel
laromestrocel [INN]
Alzheimer's Disease
$LGVNLongeveron Inc.
0 catalysts
Marketed
laronidase
Aldurazyme (laronidase)
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Genzyme Corp
0 catalysts
Marketed
larotrectinib sulfate
Larotrectinib Sulfate Bayer (larotrectinib sulfate)
Solid Tumor
Bayer HealthCare Pharmaceuticals Inc
0 catalysts
Phase 3
larsucosterol sodium
Alcoholic Hepatitis
$BHCBausch Health Companies Inc.
0 catalysts
Phase 3
laruparetigene zovaparvovec
Retinitis Pigmentosa (Retinitis)
Beacon Therapeutics Ltd
0 catalysts
Phase 2
lasmecabtagene timgedleucel
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Cellectis SA
0 catalysts
Marketed
lasmiditan
Reyvow (lasmiditan)
Migraine
Eli Lilly and Co
0 catalysts
Phase 1
lasmotinib
lasmotinib [INN]
Refractory Acute Myeloid Leukemia
Pharos iBio Co Ltd
0 catalysts
Phase 3
lasofoxifene tartrate
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Estrogen receptor
$LONALeonaBio, Inc.
0 catalysts
Marketed
latanoprostene bunod
Vyzulta (latanoprostene bunod)
Ocular Hypertension
$BLCOBausch & Lomb Corp
0 catalysts
Phase 3
latarcibart
latarcibart [INN]
Von Willebrand Disease (vWD)
$STHOStar Holdings
0 catalysts
Phase 1
lecomkafusp alfa
lecomkafusp alfa [INN]
Adenocarcinoma Of The Gastroesophageal Junction
$HOWLWerewolf Therapeutics, Inc.
0 catalysts
Marketed
lefamulin acetate
Xenleta (lefamulin acetate)
Community-Acquired Bacterial Pneumonia
Nabriva Therapeutics US Inc
0 catalysts
Phase 1
lefelsiran sodium
Alcohol Use Disorder (AUD)
Novo Nordisk AS
0 catalysts
Phase 1
lefitolimod
lefitolimod [INN]
Solid Tumor
Mologen AG
0 catalysts
Marketed
lemborexant
Dayvigo (lemborexant)
Insomnia
Eisai Co Ltd
0 catalysts
Phase 2
lenacapavir + teropavimab + zinlirvimab
Human Immunodeficiency Virus (HIV) Infections (AIDS)
$GILDGILEAD SCIENCES, INC.
0 catalysts
Phase 3
lenadogene nolparvovec
LUMEVOQ (lenadogene nolparvovec [INN])
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy)
GenSight Biologics SA
0 catalysts
Marketed
leniolisib
Joenja (leniolisib [INN])
Common Variable Immunodeficiency (CVID)
Pharming Group NV
0 catalysts
Phase 3
lepodisiran sodium
Atherosclerosis
Eli Lilly and Co
0 catalysts
Phase 2
lepunafusp alfa
lepunafusp alfa [INN]
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
JCR Pharmaceuticals Co Ltd
0 catalysts
Phase 2
lepzacitinib
Atopic Dermatitis (Atopic Eczema)
$ACRSAclaris Therapeutics, Inc.
0 catalysts
Phase 2
lerapolturev
lerapolturev [INN]
Metastatic Melanoma
Istari Oncology Inc
0 catalysts
Phase 2
leronlimab
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
C-C chemokine receptor type 5
$CYDYCytoDyn Inc.
0 catalysts
Phase 2
letetresgene autoleucel
Myxoid Liposarcoma
US WorldMeds LLC
0 catalysts